Navigation Links
Statistical tool could explain gene study variations
Date:5/28/2008

While scientists are using the human genome to associate certain genes with disease, Dr. Hongyan Xu wants to ensure they are accounting for natural variations in those genes.

"These differences can create some challenges in analyzing data," says Dr. Xu, biostatistician in the Medical College of Georgia School of Graduate Studies. "There is always some difference in ethnic backgrounds across a study population."

For instance, a study looking at a population of blacks from Augusta and blacks from Chicago wouldn't necessarily take into account the difference in subpopulations, he says.

"Some groups of blacks could have different degrees of ancestry from different African groups," he says. "Some populations of blacks have different skin tones, which indicate a difference in genetic makeup. That isn't always taken into account."

Scientists use genome-wide association studies to compare the genes of people with health conditions to the genes of healthy people, thereby better understanding basic biological processes that affect health and possibly how to better diagnose and treat disease.

Some studies account for differences by using control groups who self-report similar ethnicities. But there can be wide variations because people are not always completely aware of their ancestry, Dr. Xu says.

A computer-based statistical tool could be the answer, he says.

Dr. Xu and colleagues will start by examining an existing database from an ongoing association study of stroke risk in black children. That study, conducted by Dr. Abdullah Kutlar, hematologist/oncologist and director of the MCG Sickle Cell Center, aims to understand the genetics of stroke risk in children with sickle cell disease. With funding from the National Institutes of Health, Dr. Xu and his team will take a closer look at children already identified as high-risk because of high blood flow velocity in the brain, as measured by transcranial Doppler tests.

Previous MCG research identified high-velocity blood flow as a risk factor for stroke and regular blood transfusions as a way to reduce that risk.

"While Dr. Kutlar is looking for the underlying genetic reasons for the higher stroke risks in this sample of patients, we will be looking for ways to identify the subpopulations in that sample," Dr. Xu says. "If population structure isn't taken into account, it could affect the validity of study results."

Researchers will use a statistical approach known as coalescent theory, which traces coding sequences of genes in a population sample to a single ancestral copy of a gene. That gene would theoretically be copied in the genetics of every member of an identical population.

For instance, two people with almost identical sets of chromosomes could differ in a very small way by one structural unit that binds their DNA. By tracing it back, researchers would reach a point where the "copied" gene would not be present. That would indicate the point where two lineages joined, Dr. Xu says.

Genetic differences among the two populations could then be tagged, subcategorized and accounted for in study results, he says.

"With the coalescent theory, we focus on the samples rather than the whole population," Dr. Xu says. "That way, we can generate samples with various levels of population structure with great efficiency using computers, which are important for large-scale genome-wide studies. Understanding the genetic basis for disease is key to prevention, diagnosis and effective treatment. Developing a method that accounts for variations in the genetics of people who are similar but distinct is crucial to better understanding the genetics of health."


'/>"/>

Contact: Jennifer Hilliard
jhilliard@mcg.edu
706-721-8604
Medical College of Georgia
Source:Eurekalert  

Related biology news :

1. Research suggests parts of UK could be too hot for wine making by 2080
2. Research suggests parts of UK could be too hot for wine-making by 2080
3. Fluorescent nano-barcodes could revolutionize diagnostics
4. Molecular clock could predict risk for developing breast cancer
5. Sugar linkage could lead to better treatment for autoimmune diseases
6. Fruit fly avoidance mechanism could lead to new ways to control pain in humans
7. UF scientists discover compound that could lead to new blood pressure drugs
8. New 3-D ultrasound could improve stroke diagnosis, care
9. Inflammation triggers cell fusions that could protect neurons, Stanford research shows
10. Smithsonian scientists find evidence that could rewrite Hawaiis botanical history
11. For some who have lost their sense of smell, a once popular asthma drug could help
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statistical tool could explain gene study variations
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... Parallel6™ ... clinical trials worldwide, announced today that they were named one of the 2017 ... covers the latest developments in the pharmaceutical industry. , “We take pride in honoring ...
(Date:4/20/2017)... For today, Stock-Callers.com redirects investors, attention to Biotechnology, ... research aimed at treating diseases and medical conditions. Under evaluation ... (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), and ZIOPHARM Oncology ... complimentary research reports on these stocks now at: ... http://stock-callers.com/registration Biostage ...
(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today announced that ... after the company changed focus to making analytical tools for biopharmaceutical quality control. ... technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of ... accessible to novices as well as experienced users, attendees will gain a better ... screening tests. , Hemostasis testing quality is determined by preanalytical variables which ...
Breaking Biology Technology: